← Evidence map

ArticleAlimentary pharmacology & therapeutics2014

Editorial: safety and tolerability of rifaximin for IBS - more information is required; authors' reply.

P Schoenfeld et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 24946060